New re­port sin­gles out Big Phar­ma play­ers for ring­ing their block­busters with patents while hik­ing prices for years

What do Roche, Pfiz­er and Ab­b­Vie all have in com­mon, aside from shar­ing Big Phar­ma sta­tus?

They all have pur­sued a strat­e­gy of padding their …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.